1. Home
  2. GASS vs CRBU Comparison

GASS vs CRBU Comparison

Compare GASS & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GASS

StealthGas Inc.

HOLD

Current Price

$6.96

Market Cap

253.4M

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.71

Market Cap

203.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GASS
CRBU
Founded
2004
2011
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
253.4M
203.9M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
GASS
CRBU
Price
$6.96
$1.71
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
129.4K
1.0M
Earning Date
11-25-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.66
N/A
Revenue
$177,257,115.00
$9,295,000.00
Revenue This Year
$5.86
N/A
Revenue Next Year
N/A
$4.96
P/E Ratio
$4.32
N/A
Revenue Growth
12.23
N/A
52 Week Low
$4.82
$0.66
52 Week High
$8.18
$3.54

Technical Indicators

Market Signals
Indicator
GASS
CRBU
Relative Strength Index (RSI) 54.62 36.21
Support Level $6.69 $1.82
Resistance Level $7.25 $1.91
Average True Range (ATR) 0.20 0.10
MACD 0.02 0.01
Stochastic Oscillator 51.28 1.92

Price Performance

Historical Comparison
GASS
CRBU

About GASS StealthGas Inc.

StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: